ABSTRACT
Objective: Mortality rate is a general indicator which can be used to measure care and management of schizophrenia. This cohort study evaluated the standardized mortality ratios (SMRs) of all-cause mortality and life-years lost (LYLs) in patients with schizophrenia under a community care program in China. Methods: Data were obtained from the National Community Care Program System for Severe Mental Disorders. A total of 99,214 patients diagnosed with schizophrenia were enrolled before December 2014 and followed between 2015 and 2019. A total of 9,483 patients died. Crude mortality rates (CMRs) and SMRs were then stratified by natural vs. unnatural causes, and major groups of death were standardized according to the 2010 National Population SMRs. The corresponding LYLs at birth were also calculated by gender and age. Results: The SMRs of patients with schizophrenia were significantly elevated during the study period, with an overall SMR of 4.98 (95%CI 2.67-7.32). Neoplasms, cardiovascular diseases, cerebrovascular diseases, external injuries, and poisonings were the most significant causes of death among patients with schizophrenia compared to the general population. The mean LYLs of patients with schizophrenia were 15.28 (95%CI 13.26-17.30). Males with schizophrenia lost 15.82 life-years (95%CI 13.48-18.16), and females lost 14.59 life-years (95%CI 13.12-16.06). Conclusions: Patients with schizophrenia under community care had a high mortality rate in our study, even though mental health services have been integrated into the general healthcare system in China to narrow treatment gaps in mental health for > 10 years. In terms of mortality outcome indicators, effective and quality mental health services still have a long way to go. The current study demonstrates the potential for improved prevention and treatment of individuals with schizophrenia under community care.
ABSTRACT
<p><b>OBJECTIVE</b>To construct a breast cancer gene-drug network model for extracting and predicting the correlations between breast cancer-related genes and drugs.</p><p><b>METHODS</b>We developed an algorithm based on the ABC principle and the association rules to obtain the correlations between the biological entities. For breast cancer, we constructed 3 different correlations (gene-gene, drug-drug and gene-drug) and used the R language to implement the associated network model. The reliability of the algorithm was verified by ROC curve.</p><p><b>RESULTS</b>We identified 185 breast cancer-associated genes and 98 associations between them, 97 drugs and 170 associations between them. The breast cancer genes-drugs network contained 127 genes and 77 drugs with 384 associations between them.</p><p><b>CONCLUSIONS</b>We identified a large number of different correlations between the breast cancer-related genes and drugs and close correlations between some biological entity pairs that have not yet been reported, which may provide a new strategy for experimental design for testing personalized breast cancer treatment.</p>
Subject(s)
Female , Humans , Algorithms , Antineoplastic Agents , Pharmacology , Breast Neoplasms , Genetics , Gene Regulatory Networks , Genes, Neoplasm , ROC Curve , Reproducibility of ResultsABSTRACT
<p><b>OBJECTIVE</b>To report the application of medial neurocutaneous flap with perforator vessel in upper arm.</p><p><b>METHODS</b>Based on the perforator vessel of medial deep main blood vessel in upper arm and blood supply of neurocutaneous flap, as well as their interrelation with vascularity of fascia skin, we designed the medial neurocutaneous flap with perforator vessel in upper arm to repair skin defects in shoulder, arm and elbow joint in 5 cases.</p><p><b>RESULTS</b>All the flaps survived completely with primary healing. The patients were followed up for 6-12 months. The contour of flaps and the function of shoulder and elbow joint were satisfactory.</p><p><b>CONCLUSION</b>The neurocutaneous flap has a reliable blood supply and easily performed. It is very desirable for repairing skin defect in upper extremity.</p>